Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Fresenius SE & Co. KGaA operates in the healthcare sector, primarily focusing on dialysis services and hospital management. With a strong presence in Europe and North America, the company benefits from its vertically integrated model, which includes both manufacturing of medical devices and provision of healthcare services.
Fresenius generates revenue through its comprehensive dialysis services, which leverage its proprietary technologies and extensive patient network. The company maintains pricing power due to its established brand reputation and the critical nature of its services, while also benefiting from economies of scale in its hospital operations.
Changes in reimbursement rates for dialysis services in key markets
Regulatory changes affecting healthcare providers
Patient volume growth in dialysis centers
Mergers and acquisitions in the healthcare sector
Regulatory changes impacting reimbursement rates for dialysis services
Technological disruption from new treatment modalities or competitors
Increased competition from emerging healthcare providers and telehealth services
Potential for price pressure from government negotiations
Moderate debt levels could become a concern if interest rates rise significantly
Pension obligations could strain cash flows if not managed effectively
moderate - The healthcare sector is generally resilient during economic downturns, but Fresenius may experience pressure on elective procedures and patient volumes in hospitals during recessions.
Rising interest rates may increase financing costs for capital expenditures, impacting profitability, and could also affect valuation multiples as investors seek higher returns in fixed income.
minimal - The company has a manageable debt-to-equity ratio of 0.60, indicating limited reliance on credit markets for operations.
value - The company's stable cash flows and low valuation multiples attract value-oriented investors.
low - Historically, Fresenius has exhibited lower volatility compared to the broader market, with a beta around 0.8.